Xavier Lasserre

Xavier Lasserre is a seasoned executive in the pharmaceutical industry, currently serving as Chief Commercial Officer at Ethypharm since June 2023. Prior roles include Head of Commercial at Zentiva, where Xavier played a significant role in Sanofi's divestment of the European generic market, and Head of Operations for the Generics Franchise at Sanofi. Lasserre's extensive experience at Sandoz and Sanofi showcases a strong track record in commercial operations, market share expansion, and organizational restructuring, achieving notable sales growth and operational improvements. Lasserre holds a Master's degree in Management, Marketing, and Finance from ESCP Business School and a postgraduate degree in Neurosciences from Paris-Sud University.